BACKGROUND: This review aimed to find relevant published studies on the co-morbidity of autism and Asperger's syndrome with psychotic, anxiety and/or mood disorders, assess them, synthesize the findings, present an overview and make recommendations for future research. METHODS: Systematic literature searches were performed using several databases. Selected articles had to describe an original study that provided prevalence and/or incidence estimates on autism and/or Asperger's syndrome co-morbidity with psychotic, anxiety and/or mood disorders. RESULTS AND CONCLUSION: There is conflicting evidence regarding the frequency of schizophrenia in this population. Depression appears to be common, although most individuals with autism do not have sufficient language skills to verbalize changes in mood. Anxiety disorders represent the most common psychiatric co-morbidity in this population. Copyright 2009 S. Karger AG, Basel.
BACKGROUND: This review aimed to find relevant published studies on the co-morbidity of autism and Asperger's syndrome with psychotic, anxiety and/or mood disorders, assess them, synthesize the findings, present an overview and make recommendations for future research. METHODS: Systematic literature searches were performed using several databases. Selected articles had to describe an original study that provided prevalence and/or incidence estimates on autism and/or Asperger's syndrome co-morbidity with psychotic, anxiety and/or mood disorders. RESULTS AND CONCLUSION: There is conflicting evidence regarding the frequency of schizophrenia in this population. Depression appears to be common, although most individuals with autism do not have sufficient language skills to verbalize changes in mood. Anxiety disorders represent the most common psychiatric co-morbidity in this population. Copyright 2009 S. Karger AG, Basel.
Authors: Martien J Kas; Jeffrey C Glennon; Jan Buitelaar; Elodie Ey; Barbara Biemans; Jacqueline Crawley; Robert H Ring; Clara Lajonchere; Frederic Esclassan; John Talpos; Lucas P J J Noldus; J Peter H Burbach; Thomas Steckler Journal: Psychopharmacology (Berl) Date: 2013-09-19 Impact factor: 4.530
Authors: Min Tae M Park; Armin Raznahan; Philip Shaw; Nitin Gogtay; Jason P Lerch; M Mallar Chakravarty Journal: J Psychiatry Neurosci Date: 2018-05 Impact factor: 6.186